| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Outline of Final Research Achievements |
This study aimed to establish a detection system and surveillance framework for antiviral-resistant influenza viruses, specifically targeting resistance to the novel anti-influenza drug baloxavir marboxil developed in Japan. The research successfully developed a system for rapid detection of baloxavir-resistant viruses and provided a mechanism for timely dissemination of information to communities and medical institutions. In addition, using the detection system established in this study, we screened circulating viruses in Japan and identified human-to-human transmission of baloxavir-resistant viruses.
|
